Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
DPP4 and thyroid cancer are reported together in 1 article.
Gene
DPP4
- HGNC
- HGNC:3009
26articles
26mentions
4variants with confirmed gene link
Most co-reported phenotypes (articles)
MERS 14diabetes mellitus 4COVID-19 2SARS 2Alzheimer disease 1gastric cancer 1inflammatory bowel disease 1intellectual disability 1
Reported variants (articles · ClinVar status)
Phenotype
Thyroid cancer
216articles
216mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
1 records shown · first 60Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin.
PMID 35205190 | PMCID PMC8869712 | DOI 10.3390/biology11020324 · Biology · 2022 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | DPP4 | “Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin.” | 0.98 | hgnc_dict_v1 |
| phenotype | thyroid cancer | “Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | CTNNB1 | “Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin.” | 0.98 | hgnc_dict_v1 |